Yahoo
The stocks endured multiple headwinds during the month, especially Biohaven, which had one of its drug candidates deliver underwhelming results in a recent study. Finally, the resignation of a key Federal Food and Drug Administration (FDA) regulator toward the end of the month cast a pall over the FDA approval process under the tenure of new Secretary of Health and Human Services, Robert F. Kennedy Jr.
Yahoo
Recursion Pharmaceuticals—a relatively small company backed by the chip giant Nvidia—is betting that its massive supercomputer will give it the edge to dominate the sector.
Yahoo
Salt Lake City, UT, April 01, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, announced today its participation in the following upcoming investor conference: Needham 24th Annual Virtual Healthcare Conference — Monday, April 7, 2025 Webcasts may be found in the events section of the Recursion Investor Relations website at ir.recursion.com. About RecursionRecursion (NASDAQ: RXRX) is a clinical stage Tech
Yahoo
All three companies are early-stage biotechnology companies working on next-generation therapeutics with advanced technologies. Over the weekend, Dr. Peter Marks, who headed the FDA's Center for Biologics Evaluation and Research, as well as its vaccine division, resigned in protest.
Yahoo
Artificial intelligence (AI) is changing the world. Corporations are racing to establish themselves as leaders in the field, while investors want to cash in by putting their hard-earned money into the most promising AI companies. Two AI healthcare stocks -- Recursion Pharmaceuticals (NASDAQ: RXRX) and Teladoc Health (NYSE: TDOC) -- have lagged the market over the past year.
SeekingAlpha
Stay ahead with Seeking Alpha's Wall Street Week Ahead. Get insights on key events, earnings, IPOs, and market trends.
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
ARKG | 79.15% | $936.86M | 0.75% |
CPRJ | 71.02% | $48.38M | 0.69% |
ARKK | 68.14% | $5.03B | 0.75% |
GNOM | 67.77% | $47.13M | 0.5% |
KOMP | 64.01% | $1.95B | 0.2% |
IBUY | 62.73% | $154.71M | 0.65% |
SPHB | 61.65% | $336.39M | 0.25% |
ROBT | 61.55% | $420.42M | 0.65% |
XBI | 61.11% | $4.76B | 0.35% |
VBK | 61.08% | $17.32B | 0.07% |
QQQJ | 60.82% | $592.09M | 0.15% |
RSPA | 60.66% | $292.67M | 0% |
BUZZ | 60.39% | $48.67M | 0.76% |
XT | 60.18% | $2.97B | 0.46% |
IWO | 59.86% | $10.72B | 0.24% |
CWB | 59.81% | $3.78B | 0.4% |
DRIV | 59.61% | $295.28M | 0.68% |
SECT | 59.52% | $1.83B | 0.78% |
IWC | 59.17% | $797.08M | 0.6% |
CPSJ | 58.75% | $32.91M | 0.69% |
Double maintains 5 strategies that include RXRX - Recursion Pharmaceuticals, Inc.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
SIGI | <0.01% | $5.60B | -12.19% | 1.59% |
SYY | 0.01% | $36.84B | -5.82% | 2.69% |
EIG | 0.02% | $1.24B | +13.25% | 2.38% |
WELL | -0.06% | $99.26B | +67.72% | 1.68% |
SJW | -0.06% | $1.81B | -1.37% | 2.91% |
SAFT | -0.13% | $1.18B | -1.03% | 4.62% |
PBA | 0.15% | $23.73B | +14.96% | 4.86% |
TEF | 0.26% | $26.35B | +6.62% | 6.43% |
OGE | -0.28% | $9.34B | +35.10% | 3.61% |
ATO | 0.31% | $24.64B | +32.69% | 2.13% |
IMNN | 0.43% | $15.35M | -24.46% | 0.00% |
CINF | 0.43% | $23.11B | +21.68% | 2.30% |
VRSK | 0.45% | $42.04B | +29.74% | 0.53% |
AON | -0.49% | $85.54B | +22.05% | 0.68% |
JJSF | -0.54% | $2.55B | -5.41% | 2.31% |
CYCN | 0.54% | $7.07M | -17.41% | 0.00% |
ELS | 0.56% | $12.74B | +6.15% | 2.84% |
BTCT | -0.58% | $20.15M | +14.57% | 0.00% |
SWBI | 0.59% | $418.03M | -44.64% | 5.68% |
AMSF | -0.61% | $997.00M | +13.96% | 2.88% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -58.29% | $416.76M | 1.43% |
VIXY | -39.65% | $195.31M | 0.85% |
TAIL | -34.10% | $87.65M | 0.59% |
USDU | -19.89% | $206.96M | 0.5% |
UUP | -19.77% | $325.79M | 0.77% |
CCOR | -17.59% | $64.12M | 1.18% |
CTA | -11.78% | $978.30M | 0.76% |
IYK | -10.35% | $1.53B | 0.4% |
UGA | -6.44% | $87.23M | 0.97% |
TFLO | -5.73% | $6.75B | 0.15% |
DBE | -4.99% | $55.52M | 0.77% |
USO | -4.07% | $972.70M | 0.6% |
DBO | -3.68% | $202.41M | 0.77% |
BNO | -3.59% | $99.25M | 1% |
WEAT | -3.48% | $115.75M | 0.28% |
TBIL | -2.68% | $5.39B | 0.15% |
BIL | -2.46% | $41.88B | 0.1356% |
UNG | -2.33% | $397.59M | 1.06% |
FTXG | -2.25% | $26.06M | 0.6% |
XLP | -2.17% | $16.87B | 0.09% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CRSP | 69.06% | $2.93B | -47.07% | 0.00% |
BEAM | 61.99% | $1.85B | -37.74% | 0.00% |
NTLA | 59.30% | $755.67M | -70.78% | 0.00% |
SW | 54.64% | $24.56B | +1.82% | 2.42% |
NNOX | 53.50% | $287.24M | -54.79% | 0.00% |
AEIS | 52.65% | $3.64B | -2.74% | 0.48% |
ABCL | 52.12% | $661.53M | -49.32% | 0.00% |
KN | 51.96% | $1.34B | -5.22% | 0.00% |
SLAB | 51.79% | $3.79B | -13.44% | 0.00% |
SOFI | 50.94% | $13.50B | +63.26% | 0.00% |
ROKU | 50.89% | $10.43B | +14.79% | 0.00% |
FATE | 50.49% | $88.24M | -89.02% | 0.00% |
LFUS | 49.90% | $4.86B | -17.85% | 1.62% |
SDGR | 49.22% | $1.45B | -20.13% | 0.00% |
VSH | 48.90% | $2.16B | -28.21% | 2.94% |
OPEN | 48.80% | $730.75M | -64.81% | 0.00% |
IMNM | 48.03% | $583.44M | -68.94% | 0.00% |
ALLO | 47.99% | $312.86M | -64.79% | 0.00% |
MKSI | 47.71% | $5.48B | -38.72% | 1.27% |
TWST | 47.67% | $2.28B | +14.61% | 0.00% |
Current Value
$4.911 Year Return
Current Value
$4.911 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BILZ | 0.17% | $734.41M | 0.14% |
ULST | 0.18% | $585.14M | 0.2% |
KMLM | 0.50% | $218.49M | 0.9% |
COMT | 0.64% | $684.20M | 0.48% |
CLOA | 0.72% | $783.46M | 0.2% |
GSG | -0.72% | $1.05B | 0.75% |
AGZD | 1.09% | $134.05M | 0.23% |
USFR | 1.43% | $18.53B | 0.15% |
TPMN | -1.46% | $33.32M | 0.65% |
IVOL | -1.48% | $476.36M | 1.02% |
OILK | -1.65% | $67.85M | 0.69% |
USL | -1.68% | $47.77M | 0.85% |
XHLF | -1.84% | $1.06B | 0.03% |
JMST | 1.89% | $3.54B | 0.18% |
XLP | -2.17% | $16.87B | 0.09% |
FTXG | -2.25% | $26.06M | 0.6% |
UNG | -2.33% | $397.59M | 1.06% |
FXY | 2.40% | $549.84M | 0.4% |
BIL | -2.46% | $41.88B | 0.1356% |
TBIL | -2.68% | $5.39B | 0.15% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CBOE | -29.43% | $23.50B | +25.53% | 1.05% |
ED | -20.53% | $38.69B | +21.90% | 2.95% |
PG | -19.39% | $397.45B | +8.55% | 2.32% |
CHD | -19.39% | $26.66B | +5.00% | 1.03% |
CME | -18.93% | $94.61B | +23.82% | 3.89% |
DUK | -17.45% | $93.55B | +25.45% | 3.37% |
CLX | -15.78% | $18.19B | +0.54% | 3.24% |
KMB | -15.21% | $47.39B | +13.36% | 3.37% |
MO | -15.19% | $96.57B | +35.61% | 6.83% |
SO | -14.78% | $100.14B | +28.63% | 3.09% |
NOC | -14.31% | $74.14B | +12.07% | 1.60% |
LMT | -14.25% | $106.60B | +1.11% | 2.84% |
PEP | -14.14% | $204.52B | -12.12% | 3.52% |
AEP | -12.58% | $57.54B | +27.77% | 3.31% |
GIS | -12.51% | $32.41B | -14.20% | 3.90% |
CL | -12.10% | $75.88B | +6.19% | 2.07% |
CB | -12.05% | $120.74B | +18.35% | 1.19% |
T | -11.96% | $201.99B | +59.80% | 3.85% |
D | -11.57% | $47.91B | +15.63% | 4.73% |
PGR | -11.41% | $164.86B | +33.43% | 1.71% |